Emilio José
Sanz Álvarez
Catedrático de Universidad
Centro de Investigacion Biomedica en Red de Salud Mental
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Centro de Investigacion Biomedica en Red de Salud Mental (10)
2024
-
Adverse drug reactions and their fatal outcomes in clozapine patients in VigiBase: Comparing the top four reporting countries (US, UK, Canada and Australia)
Schizophrenia Research, Vol. 268, pp. 165-174
-
An expert review of clozapine in Eastern European countries: Use, regulations and pharmacovigilance
Schizophrenia Research, Vol. 268, pp. 53-59
-
An expert review of clozapine in Latin American countries: Use, monitoring, and pharmacovigilance
Schizophrenia Research, Vol. 268, pp. 60-65
-
Clozapine may consistently protect from suicidal behaviors while other antipsychotics may lack a specific protective effect: a comprehensive VigiBase study interpreted in the context of the prior literature
Expert Opinion on Drug Safety
-
Clozapine-associated pericarditis and pancreatitis in children and adolescents: A systematic literature review and pharmacovigilance study using the VigiBase database
Schizophrenia Research, Vol. 268, pp. 118-130
-
Investigating in VigiBase over 6000 cases of pneumonia in clozapine-treated patients in the context of the literature: focus on high lethality and the association with aspiration pneumonia
Expert Opinion on Drug Metabolism and Toxicology, Vol. 20, Núm. 8, pp. 857-871
-
Revealing the reporting disparity: VigiBase highlights underreporting of clozapine in other Western European countries compared to the UK
Schizophrenia Research, Vol. 268, pp. 175-188
2023
-
Escaping the Long Shadow Cast by Agranulocytosis: Reflections on Clozapine Pharmacovigilance Focused on the United Kingdom
Journal of Clinical Psychopharmacology, Vol. 43, Núm. 3, pp. 239-245
-
Respiratory aspiration during treatment with clozapine and other antipsychotics: a literature search and a pharmacovigilance study in vigibase
Expert Opinion on Drug Metabolism and Toxicology, Vol. 19, Núm. 2, pp. 57-74
2022
-
Clozapine-induced myocarditis in children and adolescents: a pharmacovigilance study using VigiBase and a systematic literature review
Expert Opinion on Drug Metabolism and Toxicology, Vol. 18, Núm. 11, pp. 715-727